During the first week after treatment there was elevation of AST and ALT below 2xULN as well as mild thrombocytopenia of 167 that both resolved afterwards CHOP-INTEND scores were 23, 35, 43 and 48 on follow-up at 1, 3, 6 and 12 months, respectively. This evidence concerns the gene GPT and Thrombocytopenia.